(F13.8) Mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders

More details coming soon

Icon
653 417 in individuals diagnosis mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders confirmed
Icon
2 867 deaths with diagnosis mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders

Diagnosis mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders is diagnosed Women are 10.68% more likely than Men

291 801

Men receive the diagnosis mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders

1 390 (0.5 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
361 616

Women receive the diagnosis mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders

1 477 (0.4 %)

Died from this diagnosis.

Risk Group for the Disease mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders - Men aged 30-34 and Women aged 55-59

Icon
In Men diagnosis is most often set at age 0-94
Icon
Less common in men the disease occurs at Age 0-1, 95+Less common in women the disease occurs at Age 0-1
Icon
In Women diagnosis is most often set at age 0-95+

Disease Features mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders

Icon
Absence or low individual and public risk
Icon

Mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders - what does this mean

Mental and behavioural disorders due to the use of sedatives or hypnotics are caused by the long-term use of these drugs, which can lead to changes in the brain's chemistry and structure. this can manifest in a variety of symptoms, including changes in mood, motivation, and behaviour, as well as impaired cognitive functioning. in some cases, these effects can be severe enough to interfere with daily life.

What happens during the disease - mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders

The pathogenesis of mental and behavioural disorders due to use of sedatives or hypnotics is a complex process involving the alteration of neurotransmitter levels in the brain, leading to changes in cognition, mood, and behaviour. these changes can be caused by a variety of factors, including the type and amount of sedative or hypnotic used, the duration of use, and the individual's underlying mental health. the symptoms of this disorder can range from mild to severe, and can include anxiety, depression, confusion, agitation, and impaired judgement.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Psychological evaluation
  • Urine or blood tests
  • Imaging tests such as MRI or CT scans
  • Neuropsychological testing
  • Lab tests to check for drug interactions
  • Psychotherapy
  • Medication management
  • Family therapy
  • Group therapy
Additions:
  • Substance abuse counseling
  • Support groups

Treatment and Medical Assistance

Main goal of the treatment: To reduce the symptoms of mental and behavioural disorders due to the use of sedatives or hypnotics.
  • Psychotherapy
  • Cognitive behavioural therapy
  • Medication such as antidepressants
  • Counselling and support
  • Relaxation techniques such as yoga and meditation
  • Exercise and physical activity
  • Nutritional advice and dietary changes
  • Social skills training
  • Stress management strategies
Icon
41 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Mental and behavioural disorders due to use of sedatives or hypnotics : other mental and behavioural disorders - Prevention

The best way to prevent mental and behavioural disorders due to use of sedatives or hypnotics is to limit their use and practice caution when using them. it is important to use the lowest effective dose for the shortest possible time, and to discuss any potential risks with a doctor. it is also important to avoid using alcohol or other drugs in combination with sedatives or hypnotics. finally, it is important to seek help if any signs of mental or behavioural changes occur.

Specified forms of the disease

(I42.0) Dilated cardiomyopathy
(I42.1) Obstructive hypertrophic cardiomyopathy
(I42.2) Other hypertrophic cardiomyopathy
(I42.3) Endomyocardial (eosinophilic) disease
(I42.4) Endocardial fibroelastosis
(I42.5) Other restrictive cardiomyopathy
(I42.6) Alcoholic cardiomyopathy
(I42.7) Cardiomyopathy due to drugs and other external agents
(I42.8) Other cardiomyopathies
(I42.9) Cardiomyopathy, unspecified